CD47 blockade augmentation of trastuzumab antitumor efficacy dependent on antibody-dependent cellular phagocytosis.
Tsao LC, Crosby EJ, Trotter TN, Agarwal P, Hwang BJ, Acharya C, Shuptrine CW, Wang T, Wei J, Yang X, Lei G, Liu CX, Rabiola CA, Chodosh LA, Muller WJ, Lyerly HK, Hartman ZC.
Tsao LC, et al. Among authors: trotter tn.
JCI Insight. 2019 Dec 19;4(24):e131882. doi: 10.1172/jci.insight.131882.
JCI Insight. 2019.
PMID: 31689243
Free PMC article.